Genetic factors Certain genetic and ethnic groups have an increased risk of prostate cancer. In the U. S., prostate cancer R prostate data is at least 60 percent more common and 2 to 3 times more deadly among black men than non-Hispanic white men. A man also has a much higher risk of developing cancer if his identical twin has it, and a man whose brother or father had prostate cancer has twice the R prostate data risk of developing it compared to other men. Having a brother who has or has had prostate cancer is more of a genetic risk than having a father with the r prostate data R prostate data disease. Diet Studies have suggested that a diet high in red meat or high-fat dairy products may increase a person's chances of developing prostate cancer, but the link is neither confirmed nor clear. Medication Some R prostate data research has suggested that non-steroidal anti-inflammatory drug (NSAID) use may reduce the risk of prostate cancer. Others have linked NSAID use with a higher risk of death from the disease. This is a controversial area, and results have not been confirmed. There has also been some investigation into whether statins might slow the progression of prostate cancer. One 2016 r prostate data study concluded that results were "weak and inconsistent." R prostate data Obesity It is often believed that obesity is linked to the development of prostate cancer, but the American Cancer Society maintains that there is no clear link. Some studies r prostate data R prostate data have found that obesity increases the risk of death in advanced cancers. Studies have also concluded that obesity decreases the risk that a cancer will be low-grade if it R prostate data does occur. Agent Orange Exposure to Agent Orange, a chemical weapon used in the Vietnam war, may possibly be linked to the development of more aggressive types of cancer, but the extent of this has not been confirmed. This condition is known as Benign Prostatic Hyperplasia (or prostate adenoma) because it refers to the non-malignant growth of prostatic tissue R prostate data in men from middle age onwards. In a young man, the prostate gland is at an almost undetectable rudimentary stage, and spreads across the coating of the urinary tract like a cluster of seeds. However, during puberty, R prostate data its form begins to change due to R prostate data r prostate data the increased production of the testosterone and dihydrotestosterone hormones. Testosterone causes the "seeds", called acini, to germinate and grow. In adult life, due R prostate data to this growth and proliferation, these small R prostate data glandular structures can give rise to obstructive symptoms associated with urinary flow disorders. Benign Prostatic Hyperplasia is one of the most common diseases in men and is considered to be part of the physiological ageing process. The incidence of this disease is 51% in men aged 60 to 69, and between r prostate data 75% and 90% in octogenarians. Symptomatology Although the definition of BPH encapsulates the enlargement of the prostate and the mechanical obstruction of the flow of urine, a direct relationship between the volume of hyperplasia and the intensity of symptoms is not always present. Very enlarged prostates do not always cause symptoms and other less enlarged Prostate 1 per day organs can be a r prostate data source of intense discomfort.
The symptoms of Benign R prostate data Prostatic Hyperplasia can be divided into two categories: obstructive and irritative. Obstructive symptoms Weak R prostate data r prostate data and/or intermittent flow of urine. Double voiding (urinating for a second time within a period of 2 hours). Irritative symptoms Polyuria, or r prostate data increased frequency of urination. Nocturia, or the need r prostate data to urinate frequently during the night. Treatment of Benign Prostatic Hyperplasia Early diagnosis of Benign R prostate data Prostatic Hyperplasia is essential to avoid complications R prostate data such as urinary tract infections, damage to the kidneys or bladder, bladder stones and incontinence. The r prostate data treatment for BPH will be determined by the potential for the existence of these secondary processes that derive from urinary obstruction, along with the patient’s level of discomfort Medical treatment In patients with mild or r prostate data moderate symptoms, a pharmacological treatment can be administered that is based on alpha-blockers and alpha-reductase r prostate data inhibitors, which can help to improve urinary flow.
Stage x prostate cancer
Prostate wiki
Stage 7 prostate cancer survival rate
Prostate 60cc
| 02.04.2018 - PrinceSSka_OF_Tears |
| Most prostate cancers grow slowly and don’t. |
| 02.04.2018 - BRIQADIR |
| Cancer Prostate cancer often does not cause. |
No comments:
Post a Comment